ev3 Inc. Introduces Two New Enhanced Offerings For the Treatment of Peripheral Artery Disease

PLYMOUTH, Minn.--(BUSINESS WIRE)--ev3 Inc. (NASDAQ:EVVV), today announced the U.S. launch of the company’s most recent additions to the SilverHawk family of products: the SilverHawk® LS-M and MS-M. These devices are among the latest in plaque excision technology and are designed to treat lesions in arteries above the knee for patients suffering from peripheral artery disease (PAD).

MORE ON THIS TOPIC